BBIBP‐CorV – Sinopharm‐Beijing vs placeboAny adverse eventh1 finding from 1 reviewEfficacy and safety of COVID‐19 vaccines 2022 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 26924 participantsLow